We developed a multi-scale model of hepatitis C virus infection.
Patient-level processes and molecular details of viral replication are considered.
Our model reproduces clinical time-course data of viral load under antiviral treatment.
We predict treatment efficacy of daclatasvir can be improved by combination therapy.